Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience. It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey. Read More
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers.
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This added layer of uncertainty reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 9.5%. This drop was worse than the S&P 500’s 2.3% loss.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.
Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best Healthcare Software Products category. As the world’s largest and most trusted software marketplace, G2 reaches 100 million buyers annually. Its annual Best Software Awards rank the world’s best software companies and products based on authentic, timely reviews from real users. Phreesia’s digital solutions enhance the patient experience and drive efficiency for healthcare providers.
Healthcare technology company Phreesia (NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.11 per share was 35% above analysts’ consensus estimates.
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025.
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sally Thayer, Vice President of Product Management, has been named to The Software Report’s list of the Top 50 Women Leaders in Software of 2024.
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter and fiscal year 2025 financial results after the close of market trading on Wednesday, March 12, 2025. Phreesia will issue a press release announcing its quarterly and full year results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal fourth quarter and fiscal year 2025 results starting at 5PM Eastern Time on the same day.
